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Abstract
This article contains highlights and a selection of the scientific advances from the European 
Respiratory Society's General Pneumology Assembly that were presented at the 2019 
European Respiratory Society International Congress in Madrid, Spain. The most relevant 
topics from the different groups will be discussed, covering a wide range of areas including 
rehabilitation and chronic care, general practice and primary care and M-health and E-health. 
In this review, the newest research and actual data as well as award-winning abstracts and 
highlight sessions will be discussed.
Short abstract
A highlights review of selected presentations from #ERSCongress 2019 by the @ERStalk 
General Pneumology Assembly.
Introduction 
The European Respiratory Society International Congress is the world’s largest scientific and 
educational conference in the field of respiratory medicine. For the Madrid 2019 Congress, 
4,315 abstracts were accepted for presentation. The General Pneumology Assembly of the 
European Respiratory Society (ERS) is the largest of the 14 assemblies. In total 317 abstracts 
were presented in 20 sessions related to this assembly and the 4 groups of which it consists. 
It is impossible for any delegate to follow all scientific and clinical advances and breakthroughs 
presented during this conference. This review aims to provide the esteemed reader with an 
overview of a few of the most interesting presentations of each group, deemed noteworthy 
by the authors of this manuscript. 
Pulmonary rehabilitation and chronic care
Session: Best abstracts in pulmonary rehabilitation and chronic care
The researchers of this session presented works on various important issues in pulmonary 
rehabilitation (PR), ranging from optimizing and maintaining the effects of exercise training to 
behavioral changes.
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Because exercise intolerance often goes hand-in-hand with hypoxemia in patients with 
idiopathic pulmonary fibrosis (IPF), devices allowing a higher O2 flow are of interest. 
Schneeberger et al. [1] compared a novel device of supplemental oxygen therapy (SOT), the 
Oxymizer®, to the conventional nasal cannula (CNC) in 26 IPF patients with SOT indication. 22 
patients completed two endurance shuttle walk test using, in a randomized cross-over design, 
both Oxymizer or CNC. The use of Oxymizer® instead of CNC improved walking capacity and 
SpO2 and was associated with lower heart and breathing rate. Despite these effects, a majority 
of patients (64%) still preferred the CNC for daily use. The authors concluded that offering SOT 
through Oxymizer® could provide clinically relevant benefits for IPF patients. 
Additional prognostic information in COPD patients can be provided with the assessment of 
functional and exercise capacity but, this assessment is difficult to implement in care context. 
Thus, Walsh et al. [2] aimed to test the prognosis value of 4 metre gait speed (4MGS) in a 
cohort of 371 patients with COPD attending hospital outpatient clinics. In a multivariate 
analysis, they compared the predictive values of 4MGS, Age, FEV1 and Sex (GAFS) index to the 
Age Dyspnoea Obstruction (ADO) index and FEV1. GAFS was predictive of 3-years mortality 
with a better discrimination than the other indexes, with an area under the curve (AUC) of 
0.74. The model was also validated in an independent cohort of 472 patients attending 
community COPD clinics. The AUC for this cohort was 0.74. The authors concluded that gait 
speed can provide additional prognostic information than ADO or FEV1 alone in COPD 
patients, in a feasible manner. 
Duarte-Natália et al. [3] conducted a randomized-controlled trial to investigate whether a 
behavioral change intervention can improv  asthma control through an increase of physical 
activity levels (PAL). Control group (CG) and intervention group (IG) followed the same usual 
care intervention, with an addition of 8 weeks of behavioral change intervention focused on 
goal-setting and feedback for the IG group. The intervention had significant beneficial effects 
compared to CG on asthma clinical control, health related quality of life and PAL. Because 
improvement in asthma clinical control and PAL were correlated, the authors suggested that 
beneficial effects of the behavioral change intervention on asthma clinical control were 
mediated by PAL increase. 
A randomized double-blind, cross-over, study conducted by Bonnevie et al. [4] aimed to 
investigate whether non-invasive high and/or low frequency lumbar transcutaneous electrical 
nerve stimulation (HF or LF TENS) can improve endurance capacity of COPD patients, as 
previously shown with intrathecal administration of fentanyl. To meet these objectives, 10 
COPD patients performed in a randomized order 3 constant workload exercise associated with 
3 modalities of stimulation, a sham TENS, a LF TENS at 4Hz, or a HF TENS at 100 Hz. LF and HF 
TENS did not induce differential effects compared to the sham condition on dyspnea, lower 
limb fatigue and endurance capacity. However, muscle oxygenation tended to be higher in 
both TENS conditions compare to sham, reflecting, according to the authors, a modulation of 
the quadriceps muscle activity. 
While muscle dysfunction is well described in COPD patients, evidence regarding temporal 
muscle mRNA responses to both aerobic exercise training (AET) and training cessation (TC) are 
lacking. Latimer et al. [5] conducted a trial in 19 COPD patients and 10 healthy controls (HC) 
investigating mRNA response after 1, 4 & 8 weeks of AET and 4 weeks after TC.  94 mRNAs 
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involved in the response to AET were quantified with RT-qPCR from muscle biopsies 
performed at each time. The authors observed a lack of increase in VO2PEAK following exercise 
training in COPD patient compare to HC. However, the muscle mRNA levels were altered in a 
similar manner in COPD patients and HC in response to AET and TC. The authors concluded 
that skeletal muscle mRNA responsiveness to AET was not blunted and dissociated from the 
whole-body VO2PEAK.
A survival advantage has been described before for COPD patients who completed pulmonary 
rehabilitation (PR). Extracting the data from the Office for National Statistics concerning Wales 
and England from Jan 2015 to Jan 2017, Evans et al. [6] aimed to identify whether the case-
mix severity differences or the effects of PR themselves explained this advantage. 7092 COPD 
patients were included. 58% of the patients completed PR and these patients differed from 
the non-completer group on age, dyspnea, comorbidities occurrence, walking distance, home 
oxygen use, smoking status and hospital admission. The mortality rate was lower in the 
completer group even with an adjustment on the parameters described above. This study 
described a higher cumulative mortality in patients who did not completed PR, HR 1.42 [1.20 
to 1.67], after adjustment for confounding factors. 
While the beneficial effects of PR in COPD patients are well described, little is known about 
strategies allowing long term maintainenance of these benefits. Blervaque et al. [7] assessed 
the efficiency of a pragmatic maintenance program in COPD patients, with a follow-up of 5 
years. This program included weekly supervised exercise training sessions completed with 
discussion groups and health education. 144 COPD patients were included. The significant 
benefit provided by the PR on 6MWD remain significant up to 48 months after the PR 
discharge in the COPD patients involved in the maintenance program. In the same way, the 
benefits on dyspnea (MRC scale) and quality of life (VQ11 questionnaire) were maintained up 
to 5 years and 4 years respectively. 
General Practice and Primary care
Session: Diagnosis and assessment of airway diseases in primary care
There was a wide range of primary care content at the 2019 ERS Congress.  The Primary Care 
Day focussed on infections, vaccinations, and case studies with excellent speakers on day-to-
day respiratory cases. Our highlights this year come from the primary care oral presentations 
on Sunday 29th September, showcasing research into the diagnosis and assessment of airway 
diseases.
Benítez Pérez et al., [8] explained that spirometry training in Mexico is optional, and rarely 
performed in primary care. Addressing this, an education programme was delivered to 439 
primary care clinicians. Initial testing identified 33% of participants did not know how to 
perform spirometry, and 37% had no equipment. The education programme demonstrated a 
great improvement in participant knowledge. A second phase of training including 
certification of spirometry was delivered 10 months later, however, due to high staff turn-
over, only 70 of the original participants attended. Future research will consider condensing 
education and certification into one instalment and increasing spirometry availability.
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In the Netherlands, spirometry is straightforward to achieve, but the quality compared to 
American Thoracic Society (ATS)/European Respiratory Society (ERS) standards [9] is unclear. 
To investigate, van de Hei et al., [10] assessed usefulness and quality of spirometry from 149 
primary care patients. 88% of spirometry readings were considered ‘clinically useful’ by 
clinicians (two pneumonologists, 15 GPs), meaning they felt able to make a diagnosis from 
spirometry and available clinical data. However, when compared to the ATS/ERS standards 
only 13% of readings met the full criteria. Furthermore, when clinician diagnoses were 
compared, there was little agreement between the pulmonologists (kappa=0.38 95%CI 0.27 
to 0.50), or between general practitioners and pulmonologists (vs pulmonologist 1 kappa=0.39 
95%CI 0.22 to 0.44; vs pulmonologist 2; kappa=0.44 95%CI 0.32 to 0.55). These data suggest 
that meeting the ATS/ERS criteria was not necessary for clinicians to feel confident in making 
a diagnosis, though agreement between pulmonologists and between pulmonologists and 
GPs was poor. 
Even if spirometry quality is sufficient, demonstrating expiratory airflow limitation in asthma 
can be difficult. Bronchial provocation can be useful in the diagnostic assessment of asthma 
[11] but is traditionally performed in hospitals [12].  Therefore, Bins et al., [13] investigated 
the safety and usefulness of community performed bronchial provocation in a Dutch primary 
care diagnostic centre. 998 patients underwent histamine bronchial provocation with no 
adverse events. The authors concluded bronchial provocation of adults in the community was 
safe and feasible, could reduce the number of referrals to secondary care and that under- and 
over-diagnosis of asthma occurred if bronchial provocation was not used.
Objective tests are also used to monitor asthma control. To monitor children, guidelines 
recommend measuring lung function routinely and, in some circumstances, Fractional exhaled 
Nitric Oxide (FeNO) [14,15].  Spirometry and FeNO are used regularly in hospitals but less 
commonly in primary care. To investigate the value of spirometry and FeNO for monitoring 
asthma in primary care children, Lo et al., [16] trained staff in 10 general practices to perform 
the tests in the United Kingdom. Of the 612 children recruited with ‘GP diagnosed asthma’ or 
‘suspected asthma’, 575 achieved spirometry and 472 completed FeNO. 46% of children with 
available FeNO and spirometry reported good control (Asthma Control Test (ACT)/Children’s 
Asthma Control Test (CACT) >19) but had at least one abnormality identified by objective tests. 
Interestingly, 49% of the 191 reporting poor control (ACT/CACT ≤19), had normal spirometry 
and FeNO <35. These data suggest that assessing asthma in primary care using symptoms, or 
objective tests in isolation will not provide a full picture of the child. 
Two studies considered how to optimise management of adults with COPD. Firstly, Baron et 
al., [17] investigated asthmatic traits in 3532 individuals with pulmonologist-diagnosed COPD 
or Asthma COPD Overlap (ACO). Over 60% had at least one ‘asthma sign’. 7% had a history of 
asthma, 13% had reversibility of ≥12% and 16% had atopy. They concluded that asthma traits 
could help primary care clinicians consider which individuals with COPD are most likely to 
benefit from inhaled corticosteroids [18]. Secondly, Jordan et al. [19] presented a prediction 
model to identify COPD patients at risk of hospitalisation. Age, COPD Assessment Test score, 
percentage of predicted Forced Expiratory Volume in 1 second, respiratory admissions in the 
past year, BMI and diabetes were valuable predictors for an individual being admitted within 
2 years. The model performed well (c-statistic 0.75, 95%CI 0.72 to 0.79) and will be externally 
validated.  
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The final abstract investigated the value of the STOP-BANG questionnaire (SBQ) [20] in 
identifying individuals with Obstructive Sleep Apnoea (OSA). Plana Pes et al., [21] recruited 
565 primary care adults (30-70 years). 38% scored ≥3 on the SBQ and underwent home 
polysomnography. Of these, 93% were diagnosed with OSA. The team concluded an SBQ ≥3 
could be an adequate threshold to screen for OSA in primary care. 
Overall, the session highlighted the breadth of research topics and methods used to 
investigate clinical questions arising from primary care. Learning from researchers across 
different countries helped address shared goals and challenges arising from efforts to 
maximise the value of new and existing questionnaires, models and tests to improve the 
diagnosis and management of respiratory disease.   
M-health/E-health
Session: M-health/E-health poster discussion session
This year the ERS experienced the birth of the special interest Group M-Health/e-health, in 
the General Pneumology Assembly. This new group actively invites respiratory researchers, 
scientists, patient organisations, industry representatives, technicians and statisticians with 
experience in digital technologies to become a part of this movement and to contribute with 
their specific knowledge. At the M-Health/e-health poster discussion session, we got a 
marvellous first glimpse of the future of respiratory medicine and were provided with a 
selected sample of current initiatives. 
Telemedicine
Telemedicine is a very promising field of medicine, especially for hospitals caring for rural 
areas, because it provides a way to overcome travelling distances. Additionally, it allows for 
further communication and checks, which would not be convenient in a regular setting. During 
the session de las Heras et al. presented the results of a randomized controlled trial in patients 
with idiopathic pulmonary fibrosis (IPF) comparing usual care to Tele-rehabilitation with a 
Virtual Autonomous Physiotherapist Agent (VAPA), on exercise capacity and quality of life  
[22]. They showed that Tele-rehabilitation with VAPA is feasible for IPF and found a significant 
difference in the 6-minute walking distance. Vilarinho et al. presented the results of the 
introduction of continuous telemonitoring in home-mechanical ventilation. In 8% of patients, 
they found a clinically relevant situation to act, which could be solved with just a phone call in 
87% of cases [23]. This telemedicine troubleshooting could enhance the compliance of long-
term therapy in Home Respiratory Therapies.
Health apps
In recent years, taking into account the growing number of smartphone users, we have seen 
apps rapidly taking on a central role in people’s lives. They can be used to promote self-
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management, follow-up disease outcomes, early detect deterioration and provide 
information on a variety of issues. At our session, Rijssenbeek-Nouwens et al. showed that 
quality of life and asthma control remained at a higher level in asthma patients after 
pulmonary rehabilitation if they used an e-health support platform compared to those who 
received usual care. Interestingly, this was particularly so for high engagers of the e-health 
system, suggesting that this is an important parameter to measure [24]. Amaral et al. 
displayed a beautifully created app for children, making use of gamification to increase 
adherence [25]. Children had to perform a forced expiratory manoeuvre that was registered 
by their smartphone’s microphone. This resulted, if performed properly, in a dragon creating 
a huge fireball, which blew away a structure and interestingly, if performed sub-optimally, in 
smaller fireballs. The use of the app meant children performed spirometry unknowingly, and 
optimal performance was incentivised, in an intuitive and fun way. Puig Sanchez et al. 
presented trial results comparing a newly developed stop smoking app to usual care [26]. It 
included motivational texts upon request and mini-games, which patients could start when 
they felt the need for a smoke. They showed significantly increased cessation rates, which was 
all the more impressive considering most patients in the intervention group hardly used the 
app. A low uptake in app usage was a common feature across different presentations. Future 
research should focus on user-engagement from the start, for example by incorporating end-
users in the design phase of the app. 
Devices
The stethoscope is one of the defining features of the doctor, featuring prominently around 
the neck in movies or television series that include doctor. But, what if this stethoscope 
doesn’t actually need the doctor anymore? This is the central question that Grzywalski et al. 
sought to answer by assessing multiple respiratory sounds with plug-in stethoscopes with 
automatic sound detection and analysis [27]. This automated device was significantly better 
at detecting different respiratory sounds than doctors. Fortunately, health professionals are 
still required to interpret the plug-in stethoscope in the context of medical history and other 
tests. However, it does paint a future whereby the actual presence of the patient inside the 
hospital might no longer be required for all diagnostics. Another important area of innovation 
is the emergence of Quantified Self and the use of all sorts of wearable. Mannée et al. 
presented the first model of an easy to use smart shirt, specifically designed to assess tidal 
volumes during different types of daily activity [28]. This could be used at home instead of 
having to come to the clinic for exercise testing.  
Arteficial Intelligence (AI)/Big data
Arteficial Intelligence and machine learning techniques are of great interest for many involved 
in mhealth. Of course, it presents a very promising new field of medicine, with hopeful reports 
of earlier detection and more personalised treatment of all sorts of diseases. Demchuk et al. 
showed an automated decision support system providing personalised treatment advice for 
pneumonia, taking into account all comorbidities and interactions with other medication [29]. 
This resulted in significantly fewer medication errors. However, the use of AI in medicine is 
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certainly not a field without controversy. AI provokes interest as it is potentially superior to 
existing methods of analysis but also uncertainty as data analysis by neural networking is not 
well understood. This poses the question: “Should we follow the advice of a system if we do 
not understand how the system came to that advice?” Interestingly, Das et al. presented a 
new type of pulmonary function interpretation algorithm that shed some light on which 
determinants played a role in AI decision making and provided a new score that gives an 
indication of whether AI is right or not [30]. Hopefully, with further development , we can get 
more of a grip on how to use AI in the future and understand it better. 
The ERS Congress 2019 has been of great interest for those engaged in digital medicine. As 
well as presentations, the new Group M-Health/E-Health had their first meeting and shared 
ideas for next years’ conference, to present in the digital health sessions.
Concluding remarks
The authors of this article hope that this short summary of the impressive amount of lung 
research and advances in pulmonary care presented through the General Pneumology 
Assembly of the ERS creates curiosity to follow up on topics of interest to each individual 
reader.
It was our goal to stimulate discussion and exchange of scientific novelties and clinical 
developments. We also hope to have encouraged the readership to attend the ERS 
International Congress 2020 in Vienna.
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